ESLA logo

Estrella Immunopharma, Inc.

ESLA
Healthcare|Biotechnology|US
$0.38
-0.03 (-8.49%)
DCF Value
$0.02
Cash / Share
$0.00
Next Earnings Report
Dec 2, 2026
EPS est. -$0.08
Financing Filings (last 12 months)
5
Shelf registrations / offering prospectuses — latest Feb 13, 2026 (424B3). Possible dilution.

Upcoming Data Readouts (1)

Jul 2027
Est. completion
P1P2B-Cell Non-Hodgkin's Lymphoma (NHL)
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
NCT06343311n=27

Recent Press Releases

Estrella Immunopharma Appoints Cynthia Pussinen as Chief Executive Officer and Chairperson of the Board of Directors
Oct 26, 2026 · Business Wire
Estrella Immunopharma Treats First Patient with Two EB103 Infusions in STARLIGHT-1 Dose-Expansion Phase
Oct 15, 2026 · Business Wire
Estrella Immunopharma Activates Intermountain Health LDS Hospital as Fifth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin's Lymphoma
Oct 14, 2026 · Business Wire
Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin's Lymphoma
Aug 11, 2026 · Business Wire

SEC Filings (47)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 29, 20268-KMaterial eventDocumentIndex
Sep 8, 20268-KMaterial eventDocumentIndex
Aug 21, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Jun 30, 20268-KMaterial eventDocumentIndex
May 27, 2026DEF 14AProxy / shareholder voteDocumentIndex
May 18, 202610-QQuarterly reportDocumentIndex
May 18, 2026NT 10-QDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 30, 202610-K/AAnnual reportDocumentIndex
Mar 18, 202610-KAnnual reportDocumentIndex
Feb 13, 2026424B3Offering prospectusDocumentIndex
Jan 23, 2026EFFECTDocumentIndex
Jan 22, 2026S-1/AIPO / offering registrationDocumentIndex
Jan 16, 2026S-1/AIPO / offering registrationDocumentIndex
Jan 13, 20268-KMaterial eventDocumentIndex
Jan 6, 20268-KMaterial eventDocumentIndex
Jan 6, 2026424B5Offering prospectusDocumentIndex
Dec 22, 2025S-1IPO / offering registrationDocumentIndex
Dec 4, 20258-KMaterial eventDocumentIndex
Nov 12, 202510-QQuarterly reportDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Sep 29, 20258-KMaterial eventDocumentIndex
Sep 26, 20258-KMaterial eventDocumentIndex
Aug 12, 202510-QQuarterly reportDocumentIndex
Aug 7, 20258-KMaterial eventDocumentIndex
Jun 5, 20258-KMaterial eventDocumentIndex
Jun 3, 20258-KMaterial eventDocumentIndex
May 29, 20258-KMaterial eventDocumentIndex
May 14, 202510-QQuarterly reportDocumentIndex
May 2, 20258-KMaterial eventDocumentIndex
Mar 25, 202510-KTAnnual reportDocumentIndex
Feb 21, 20258-KMaterial eventDocumentIndex
Feb 20, 20258-KMaterial eventDocumentIndex
Dec 23, 2024S-8Employee stock planDocumentIndex
Dec 19, 2024EFFECTDocumentIndex
Dec 17, 2024424B3Offering prospectusDocumentIndex
Dec 16, 20248-KMaterial eventDocumentIndex
Dec 12, 2024S-3Shelf registrationDocumentIndex